GlobeNewswire

CP Kelco Appoints Jennifer Aspen Mason as Sr. Vice President, Global Innovation

Del

ATLANTA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that Jennifer Aspen Mason has joined its Executive Leadership Team as Senior Vice President, Global Innovation, reporting directly to CP Kelco President Didier Viala.

A global executive with more than 20 years of industry experience, Mason has an extensive background leading science organizations with Fortune 100 companies. Most recently, she spent more than five years with Mars, Incorporated, where she served as Technology and Science Strategy Officer for all Mars segments.

In her new role, Mason is responsible for leading CP Kelco's global research and development (R&D) function, including strategic innovation imperatives to drive the company's long-term growth, as well as oversight of technical teams focused on new product innovation, process R&D and research.

"We are truly delighted to welcome Jennifer to our team, and will surely benefit from her global leadership capabilities, scientific expertise and rich industry experience," Viala said.  "In her critical role as the Global Innovation leader for our business, Jennifer will serve as a change agent across our organization, focused on ensuring CP Kelco is equipped to address the evolving needs of the customers and regional markets we serve."

Prior to joining Mars, Incorporated, Mason spent 14 years with Unilever, holding several roles of increased responsibility and working in the Netherlands, the UK, Chicago, Ill., and New Jersey. While at Unilever, she led Global R&D teams for Beverages, Food Solutions and Dressings; ran the Regional Deploy Center for the $5 billion North American Food business; and served as the R&D Director for the $2 billion North American Ice Cream unit. Upon joining Mars, Incorporated in 2011, Mason served as Vice President - R&D, Quality & Food Safety for the Mars Petcare business and managed a team of 400 R&D associates while also leading the $120 million expansion of a global innovation center. She assumed her most recent role as Technology and Science Strategy Officer at Mars in 2016.

Mason holds a Bachelor's degree in Psychology and Neuroscience from Lawrence University in Appleton, Wisc., and a PhD degree in Behavioral Pharmacology from the University of Chicago. In addition, she completed executive business programs at Henley Management College in the UK and Northwestern University's Kellogg School of Management. 

About CP Kelco
Headquartered in Atlanta, Georgia, USA, and part of J.M. Huber Corporation, CP Kelco is a leading producer of specialty hydrocolloids with offices and facilities across the globe. Featuring an extensive range of hydrocolloid solutions and serving over 100 countries, CP Kelco leverages its capabilities to bring concepts and ideas to real-world products in a broad range of applications. The company's specialty ingredients touch a wide variety of consumer and household products and industrial applications, tailored to meet the needs of regional consumers. Key product lines are Gellan GumPectinXanthan GumCellulose GumCarrageenan, Diutan Gum and Microparticulated Whey Protein Concentrate, as well as other unique biopolymers. Visit www.cpkelco.com for more information.

CONTACT:
Michele Cacdac-Jones
Office: +1 678 247 7149
Mobile: +1 770 743 0564
michele.cacdac-jones@cpkelco.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CP Kelco via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Allied Esports™ Announces Formation of World’s First Affiliate Program for Esports Venues17.12.2018 15:30Pressemelding

Allied Esports™ Property Network to Offer Members Access to Global Events and Content, Expertise in Design and Operations, and Unique Sponsorship OpportunitiesFortress Esports Joins Program with Partnership Covering Exclusive Rights to New Properties in Australia and New Zealand ORANGE COUNTY, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Allied Esports™, a global esports entertainment company, today announced the formation of the world’s first esports venue affiliate program – the Allied Esports Property Network – created for global partners interested in participating in Allied Esports’ global event programming, and licensing Allied Esports’ design, development and operations expertise for their own dedicated esports venues. The Allied Esports Property Network will provide members with access to Allied Esports’ global platform of events and content production, providing participants and viewers with integrated experiences both in-person and online. Affiliate members will be fully incorpo

Aryaka Names Cloud and Software Industry Veteran, Deepak Kumar, as Senior Vice President of Customer Success17.12.2018 15:00Pressemelding

SAN MATEO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Aryaka®, the leading SD-WAN as a Service provider, announced today that Deepak Kumar, a 20-year cloud and enterprise software industry veteran, has joined the company’s leadership team as Senior Vice President, Customer Success. "We’re thrilled to welcome Deepak to Aryaka; his leadership will help us further enhance our end-user customer experience worldwide,” said Matt Carter, CEO of Aryaka. “His expertise in building and nurturing enterprise relationships will be critical as we continue to grow in 2019 and beyond.” Before joining Aryaka, Kumar was the SVP & GM at [24]7.ai, a Sequoia portfolio company in the customer experience domain. As SVP Business Development, he was responsible for building out strategic partnerships and alliances. His hard work grew the channel driven revenue significantly. As General Manager, Kumar was responsible for the Customer Acquisition Cloud product line. The product line was built based on strategic a

Biome Grow receives new consumer sales amendment from Health Canada for its Nova Scotia brand, Highland Grow17.12.2018 14:00Pressemelding

Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to announce its Nova Scotia-based subsidiary, Highland Grow Inc. (“Highland Grow”), has received its sales authorization via an amendment to its existing license from Health Canada under the Cannabis Act. This authorization will allow Highland Grow to sell cannabis products to end consumers through appropriate medical and recreational cannabis channels, dramatically increasing product availability. The sales authorization will position Biome Grow to serve the rapidly growing domestic and international cannabis markets. "Biome Grow has been steadfast in its focus on a regional business strategy and building provincial brands that can serve the unique requirements of its local cannabis consumers. This n

Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis17.12.2018 13:30Pressemelding

DUBLIN, Ireland and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis (MS). Alkermes is seeking approval of diroximel fumarate under the 505(b)(2) regulatory pathway, and the NDA submission includes data from EVOLVE-1, a Phase 3 pivotal trial that evaluated long-term safety in relapsing-remitting MS (RRMS) with approximately 700 patients dosed with diroximel fumarate. If approved, Biogen intends to market diroximel fumarate under the brand name VUMERITY™. This name has been conditionally accepted by the FDA and will be confirmed upon approval. “Diroximel fumarate was designed to provide patients with relapsing forms of multiple sclerosis a novel oral fumarate with a differentiated

SoftServe Documentary Receives “The Best Corporate Media of Ukraine 2018” Award17.12.2018 13:00Pressemelding

25th anniversary documentary takes prize in “The Best Corporate Movie” category AUSTIN, Texas, Dec. 17, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital authority and consulting company, announces the Ukrainian Association of Corporate Media, a public organization uniting professionals in the field of marketing, PR, journalism, and advertising, recognized SoftServe in its annual competition – “The Best Corporate Media of Ukraine 2018.” SoftServe’s 25th anniversary documentary took second place in the “The Best Corporate Movie Category.” The documentary honors the company’s 25th anniversary with an inside look at how SoftServe evolved over the past quarter century to become a leading digital authority. In the documentary, SoftServe’s founders and leadership share their inspiring stories and highlight the company’s achievements over the years. “It is a great honor to receive this recognition from the Ukrainian Association of Corporate Media for our 25th anniversary documentary,” sai

Bombardier to supply a further 20 FLEXITY trams to Karlsruhe17.12.2018 10:00Pressemelding

Albtal-Verkehrs-Gesellschaft expands its fleet to 62 trams The dual-system vehicles operate on both the tram network and regional railway network BERLIN, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Global mobility solution provider Bombardier Transportation received a call-off order from Albtal-Verkehrs-Gesellschaft mbH (AVG), the transport company of the Alb valley region in southwest Germany, for the delivery of 20 further dual-system BOMBARDIER FLEXITY trams. This third order is based on a framework agreement for a total of 75 vehicles from 2009. The order is valued at approximately 87 million euro ($98 million US). The vehicles will be delivered between May 2020 and March 2021. "Striving to provide attractive local transport services, we have decided to order 20 additional dual-system vehicles from Bombardier Transportation. This will allow us to purposefully enlarge our vehicle fleet offering high-quality standards to our passengers," said Dr. Alexander Pischon, CEO of Albtal-Verkehrs-Gesel